Since prophylactic vaccination with opt-TRP1 provided the best protection against B16F10 tumor development compared with other Ag formulations in the current study, the next experiments were performed with opt-TRP1 alone unless indicated otherwise. Here, TYRP1 is linked to neoplasm.